0 التعليقات
0 المشاركات
737 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Asia-Pacific Melanoma Cancer Diagnostics Market Insights: Share, Size Report 2032Market Trends Shaping Executive Summary Asia-Pacific Melanoma Cancer Diagnostics Market Size and Share Asia-Pacific Melanoma Cancer Diagnostics Market Size The Asia-Pacific melanoma cancer diagnostics market size was valued at USD 694.93 million in 2024 and is expected to reach USD 1,315.13 million by 2032, at a CAGR of 8.3% during the forecast period...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
Asia-Pacific Ovarian Cancer Diagnostics Market: Biomarker Innovation Trends and Segment Analysis Forecast 2032"Executive Summary Asia-Pacific Ovarian Cancer Diagnostics Market Size and Share: Global Industry Snapshot Data Bridge Market Research analyses that the market is growing with a CAGR of 6.3% in the forecast period of 2023 to 2030 and is expected to reach USD 1,654.90 million by 2030 from USD 1,018.76 million in 2022. The Asia-Pacific Ovarian Cancer Diagnostics report is an ultimate...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Asia-Pacific Ovarian Cancer Diagnostics Market: Precision Medicine Trends and Strategic Forecast 2032"Executive Summary Asia-Pacific Ovarian Cancer Diagnostics Market Size and Share: Global Industry Snapshot Asia-Pacific ovarian cancer diagnostics market is expected to grow in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.3% in the forecast period of 2023 to 2030 and is expected to reach USD 1,654.90 million by...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Breast Cancer Diagnostics Market Projection: Steady Growth at 6.9% CAGRThe global landscape for breast cancer diagnostics is undergoing a fundamental shift from volume-based testing to value-based precision diagnostics. According to the latest strategic analysis by Fact.MR, the market, valued at USD 5,878 million in 2025, is poised to reach USD 6,389.41 million in 2026. This trajectory is set to continue at a steady 6.9% CAGR, propelling the industry to a...0 التعليقات 0 المشاركات 693 مشاهدة 0 معاينة
-
Cancer diagnostics: the largest karyotyping applicationMany cancers are driven by chromosomal abnormalities — translocations, deletions, or amplifications. Karyotyping and FISH are used to diagnose, classify, and monitor these cancers. The karyotyping market research study shows that cancer diagnostics holds the largest share, driven by the rising incidence of leukaemias, lymphomas, and solid tumours. What's tested? The...0 التعليقات 0 المشاركات 364 مشاهدة 0 معاينة
-
Digital Pathology and Genomic Profiling Driving Cancer Tissue Diagnostics Market GrowthThe global healthcare industry is witnessing remarkable growth in oncology diagnostics, with the Cancer Tissue Diagnostics Market playing a crucial role in early cancer detection and personalized treatment planning. Tissue diagnostics technologies are increasingly being adopted across hospitals, diagnostic laboratories, and research institutions to improve cancer diagnosis accuracy and support...0 التعليقات 0 المشاركات 135 مشاهدة 0 معاينة
-
ESR1 Mutated Metastatic Breast Cancer Diagnostics Market Growth, Comprehensive Analysis Reveals Superb Development Analysis By FMINEWARK, DE / April 7, 2026 / The global ESR1 mutated metastatic breast cancer diagnostics market is projected to grow from USD 64.61 million in 2025 to USD 92.92 million by 2035, registering a CAGR of 3.7%. Growth is driven by the rising prevalence of ESR1 mutations in metastatic breast cancer patients, increasing adoption of precision medicine, and advancements in...0 التعليقات 0 المشاركات 422 مشاهدة 0 معاينة
-
Europe Melanoma Cancer Diagnostics Market Trends Report: Size & Forecast Overview 2032Executive Summary Europe Melanoma Cancer Diagnostics Market Size and Share Across Top Segments Europe Melanoma Cancer Diagnostics Market Size The Europe melanoma cancer diagnostics market size was valued at USD 1.55 billion in 2024 and is expected to reach USD 2.59 billion by 2032, at a CAGR of 6.6% during the forecast period The market growth is largely...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Europe Ovarian Cancer Diagnostics Market Size, Share, and Regulatory Policy Impact Forecast 2032"Executive Summary Europe Ovarian Cancer Diagnostics Market Research: Share and Size Intelligence Data Bridge Market Research analyses that the market is growing with a CAGR of 6.5% in the forecast period of 2023 to 2030 and is expected to reach USD 3,093.84 million by 2030 from USD 1,874.16 million in 2022. This Europe Ovarian Cancer Diagnostics Market research report is a...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Europe Ovarian Cancer Diagnostics Market Size, Share, Biomarker Trends and Strategic Forecast 2032"Executive Summary Europe Ovarian Cancer Diagnostics Market Size and Share Analysis Report Data Bridge Market Research analyses that the market is growing with a CAGR of 6.5% in the forecast period of 2023 to 2030 and is expected to reach USD 3,093.84 million by 2030 from USD 1,874.16 million in 2022. the Europe Ovarian Cancer Diagnostics Market analysis report, the strength and...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Healthcare Infrastructure Trends MEA Ovarian Cancer Diagnostics Market Share and Strategic Forecast 2032"Global Demand Outlook for Executive Summary Middle East and Africa Ovarian Cancer Diagnostics Market Size and Share Middle East and Africa ovarian cancer diagnostics market is expected to grow in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.1% in the forecast period of 2023 to 2030 and is expected to reach USD...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
10. Global Prostate Cancer Diagnostic Solutions Market Projected to Hit USD 13.1 Billion by 2036The global landscape for prostate cancer diagnostics is undergoing a fundamental structural shift, driven by a transition from legacy screening methods to high-precision, AI-integrated molecular imaging. According to the latest market analysis by Fact.MR, the Prostate Cancer Diagnostics Market was valued at USD 5.06 billion in 2026 and is projected to surge to USD 13.12...0 التعليقات 0 المشاركات 819 مشاهدة 0 معاينة
-
Are Medical Cyclotrons Advancing Precision in Cancer Diagnosis and Treatment?Regional Overview of Executive Summary Medical Cyclotron Market by Size and Share CAGR Value The global medical cyclotron market size was valued at USD 228.20 million in 2025 and is expected to reach USD 466.85 million by 2033, at a CAGR of 9.36% during the forecast period The market report also contains the drivers and restraints for the Medical...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
-
China Clinical Trials Market: How Is the China Clinical Trials Market Strengthening Site‑Infrastructure and Investigator‑Capacity?The China Clinical Trials Market is strengthening site‑infrastructure and investigator‑capacity, turning major‑hospitals and research‑centers into professional‑clinical‑trial‑platforms. China Clinical Trials Market Investment in GCP‑compliant‑sites Leading‑hospitals are upgrading facilities, electronic‑data‑capture‑systems, and monitoring‑processes to meet global‑GCP‑standards....0 التعليقات 0 المشاركات 156 مشاهدة 0 معاينة
-
How Is Bone Marrow Biopsy Advancing Cancer Diagnosis?Key Drivers Impacting Executive Summary Bone Marrow Biopsy Market Size and Share CAGR Value Data Bridge Market Research analyses a significant growth in the global bone marrow biopsy market in the forecast period 2022-2029. The expected CAGR of global bone marrow biopsy market is tend to be around 6.3% in the mentioned forecast period The report explains the vital developments about...0 التعليقات 0 المشاركات 919 مشاهدة 0 معاينة
الصفحات المعززة
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek